Physical Activity in Pregnancy

NCT ID: NCT03277807

Last Updated: 2017-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

53 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-02-04

Study Completion Date

2013-10-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective observational study assesses whether women who regularly exercise during pregnancy show reduced low grade Inflammation, compared to women who are not regularly exercising. Furthermore, the effects of regular physical activity in pregnancy on fetal and neonatal outcomes will be investigated. 3 groups of pregnant women will be formed (group 1: regularly physically active women; group 2: physically inactive women and group 3: women with a history of preeclampsia or positive history of metabolic conditions increasing the risk of hypertensive disorders in pregnancy).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pregnancy is a natural state of low grade inflammation in the mother and the feto-placental unit. The severity of this inflammation increases with higher pregravid Body Mass Index (BMI). This is reflected by an increase in pro-inflammatory cytokines in the maternal circulation and in the placenta. It has been proposed that the pro-inflammatory maternal and fetal environment plays a role in mediating pregnancy outcomes.

In non-pregnant individuals regular physical activity is associated with a reduced inflammatory state. The overall objective of the study is to investigate the interaction of maternal physical activity and pregnancy induced low-grade inflammation in the mother and feto-placental unit, and to assess th resulting effects on prenatal and postnatal development.

Specific research objective will be to study effects of maternal physical activity on:

1. low grade Inflammation in the mother an feto-placental unit;
2. maternal and fetal lipid profiles, including High Density Lipoprotein (HDL) proteome;
3. fetal growth and infant body composition;
4. transcriptomic and epigenetic profile in the placenta;
5. biomarkers of nutritive status;
6. psychological assessment: cardiac awareness; assessment of arterial stiffness; stress-coping questionaire

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy, Physical Activity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active

pregnant women who are physically active (spend a minimum of 150min/week with moderate to vigorous physical activity)

No interventions assigned to this group

Inactive

pregnant women who are physically inactive (spend less than 150min/week with moderate to vigorous physical activity)

No interventions assigned to this group

risk for hypertensive disorders

pregnant women with a history of preeclampsia or positive history for metabolic conditions increasing the risk of hypertensive disorders in pregnancy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ongoing pregnancy no later than 14 weeks of gestation
* giving informed consent

Exclusion Criteria

* not wanting to give birth at the University Hospital
* gestational age \> 14 weeks of gestation
* 3 or more consecutive miscarriages
* increased risk to or above 1:200 after combined test (Minimum parameters: maternal age, fetal crown-rump length (CRL), nuchal translucency, nasal bone and maternal biochemistry)
* fetal anomalies associated with possible growth or genetic anomalies
* Smoking
* diagnosed with Diabetes type 1 or 2 (T1D, T2D)
* for groups 1 and 2: maternal metabolic risk factors (autoimmune conditions, increased risk for thromboembolic events needing anticoagulative therapy)
* for groups 1 and 2: pre-pregnancy hypertension
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medical University of Graz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bence Csapo, MD

Role: PRINCIPAL_INVESTIGATOR

Medical University of Graz

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 24-245 ex 11/12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Pregnancy 24/7 Cohort Study
NCT04749849 COMPLETED